| 94.23 1.22 (1.31%) | 10-14 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 110.59 |
1-year : | 129.17 |
| Resists | First : | 94.69 |
Second : | 110.59 |
| Pivot price | 88.54 |
|||
| Supports | First : | 88.83 |
Second : | 85.22 |
| MAs | MA(5) : | 91.08 |
MA(20) : | 89.05 |
| MA(100) : | 85.07 |
MA(250) : | 88.38 |
|
| MACD | MACD : | 0.4 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 94.2 |
D(3) : | 76.7 |
| RSI | RSI(14): 64.9 |
|||
| 52-week | High : | 102.91 | Low : | 72.06 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MDT ] has closed Bollinger Bands are 40.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 94.75 - 95.03 | 95.03 - 95.34 |
| Low: | 91.31 - 91.65 | 91.65 - 92.03 |
| Close: | 93.62 - 94.14 | 94.14 - 94.73 |
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Wed, 14 Oct 2026
Shareholders tendered 298M shares in Medtronic (MDT)'s oversubscribed MiniMed exchange. - Stock Titan
Wed, 14 Oct 2026
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer - PR Newswire
Tue, 13 Oct 2026
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Tue, 13 Oct 2026
45,000 Shares of Medtronic PLC $MDT Bought by Sivik Global Healthcare LLC - MarketBeat
Mon, 12 Oct 2026
Medtronic PLC (MDT) Stock Up 3.9% and Still Undervalued -- GF Sc - GuruFocus
Mon, 12 Oct 2026
Medtronic PLC Stock (MDT) Moved Up by 3.36% on Oct 12: Key Drivers Unveiled - TradingKey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 1,280 (M) |
| Shares Float | 1,280 (M) |
| Held by Insiders | 0.3 (%) |
| Held by Institutions | 88.6 (%) |
| Shares Short | 39,970 (K) |
| Shares Short P.Month | 12,130 (K) |
| EPS | 4.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 39.24 |
| Profit Margin | 13.9 % |
| Operating Margin | 19.3 % |
| Return on Assets (ttm) | 5.1 % |
| Return on Equity (ttm) | 10.6 % |
| Qtrly Rev. Growth | 13.6 % |
| Gross Profit (p.s.) | 19.14 |
| Sales Per Share | 29.32 |
| EBITDA (p.s.) | 8.13 |
| Qtrly Earnings Growth | 40.7 % |
| Operating Cash Flow | 8,030 (M) |
| Levered Free Cash Flow | 5,410 (M) |
| PE Ratio | 22.98 |
| PEG Ratio | 1.5 |
| Price to Book value | 2.4 |
| Price to Sales | 3.21 |
| Price to Cash Flow | 15.02 |
| Dividend | 0.72 |
| Forward Dividend | 0 |
| Dividend Yield | 0.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|